Patents by Inventor Gordon Broderick

Gordon Broderick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220230703
    Abstract: Disclosed is mapping complex inflammatory mechanisms in (Gulf War Illness) GWI to improve understanding of the immunologic underpinnings of GWI, the compounding effects of co-morbidity with post-traumatic stress disorder, and the potential of this co-morbidity to define a unique subtype of GWI. Predictive modeling assesses possible changes to putative treatments of GWI in the context of a probable PTSD diagnosis or lack thereof. A logic model is constructed to represent the neuroimmune system across the blood-brain barrier (BBB) connecting the central nervous system to blood-based system. Next, the model results of a GWI cohort are topologically compared with and without PTSD symptoms to mouse models of GWI in blood and use the corresponding neuroimmune states in a mouse brain to infer the blood-brain state of GWI subjects. This inference is then used to guide predictive modeling of treatment courses designed to return the overall neuroimmune system to healthy regulation.
    Type: Application
    Filed: November 29, 2021
    Publication date: July 21, 2022
    Applicant: Nova Southeastern University
    Inventors: Travis Craddock, Gordon Broderick
  • Patent number: 10777298
    Abstract: A general method of analyzing immune signaling networks for identification of potential therapeutic targets in complex, chronic medical disorders is described. The disclosure provides the CD3?/CD56+ natural killer (NK) cell population as a potential therapeutic target in the clinically-overlapping disorders Gulf War Illness (GWI) and Myalg Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The disclosure also provides a method for improving or restoring Natural Killer (NK) cell function by stimulating the NK cells with interleukin-15 (IL-15).
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: September 15, 2020
    Assignees: Nova Southeastern University, University of Miami, University of Alberta, TEC Edmonton
    Inventors: Mary Ann Fletcher, Gordon Broderick, Nancy Klimas, Zachary Barnes
  • Patent number: 5540392
    Abstract: The present invention is concerned with an improvement in the mechanical treatment of wood fibers, the improvement consisting in applying a large amount of energy at low intensity in the first stage of refining of the wood chips, and a small amount of energy at high intensity in the second stage. The present improvement allows a reduction in energy consumption as high as 18%.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: July 30, 1996
    Assignee: Noranda, Inc.
    Inventors: Gordon Broderick, Robert Lanquette, Jacques Valade